Henning Willers

7.6k total citations · 1 hit paper
142 papers, 4.8k citations indexed

About

Henning Willers is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Henning Willers has authored 142 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Henning Willers's work include DNA Repair Mechanisms (37 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Treatments and Mutations (35 papers). Henning Willers is often cited by papers focused on DNA Repair Mechanisms (37 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Treatments and Mutations (35 papers). Henning Willers collaborates with scholars based in United States, Germany and Canada. Henning Willers's co-authors include Simon N. Powell, Fen Xia, Jochen Dahm‐Daphi, Lecia V. Sequist, Harald Paganetti, Kathryn D. Held, Andrzej Niemierko, Junran Zhang, Wil L. Santivasi and Christopher G. Azzoli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Henning Willers

138 papers receiving 4.7k citations

Hit Papers

Report of the AAPM TG‐256 on the relative biological effe... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henning Willers United States 43 2.2k 2.1k 2.0k 870 732 142 4.8k
Phuoc T. Tran United States 47 2.2k 1.0× 2.5k 1.2× 2.3k 1.1× 460 0.5× 1.2k 1.6× 254 6.4k
Hirotoshi Dosaka‐Akita Japan 50 3.0k 1.4× 2.6k 1.2× 3.5k 1.7× 1.3k 1.5× 856 1.2× 164 8.4k
Pierre Verrelle France 30 1.1k 0.5× 1.1k 0.5× 946 0.5× 571 0.7× 542 0.7× 137 3.3k
Thomas Brunner Germany 43 1.9k 0.8× 1.5k 0.7× 2.9k 1.4× 737 0.8× 908 1.2× 170 5.9k
Harvey J. Mamon United States 35 1.4k 0.6× 1.3k 0.6× 1.8k 0.9× 342 0.4× 748 1.0× 154 4.5k
Jan Alsner Denmark 45 1.5k 0.7× 2.8k 1.3× 2.0k 1.0× 471 0.5× 2.6k 3.5× 176 6.6k
Ekkehard Dikomey Germany 36 959 0.4× 2.4k 1.1× 1.4k 0.7× 144 0.2× 1.0k 1.4× 115 3.9k
E.P. Malaise France 35 1.5k 0.7× 1.5k 0.7× 1.2k 0.6× 629 0.7× 1.2k 1.7× 117 4.5k
Kazuhiko Ogawa Japan 39 2.0k 0.9× 1.2k 0.6× 1.3k 0.6× 1.1k 1.2× 784 1.1× 320 5.7k
Satoshi Oizumi Japan 36 2.9k 1.3× 1.2k 0.6× 2.3k 1.2× 258 0.3× 523 0.7× 147 4.7k

Countries citing papers authored by Henning Willers

Since Specialization
Citations

This map shows the geographic impact of Henning Willers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Willers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Willers more than expected).

Fields of papers citing papers by Henning Willers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henning Willers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Willers. The network helps show where Henning Willers may publish in the future.

Co-authorship network of co-authors of Henning Willers

This figure shows the co-authorship network connecting the top 25 collaborators of Henning Willers. A scholar is included among the top collaborators of Henning Willers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Willers. Henning Willers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egan, Regina K., Jianli Ma, Jong Kung, et al.. (2025). Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models. Molecular Cancer Therapeutics. 24(6). 920–930. 1 indexed citations
2.
Mak, Raymond H., Michael Lanuti, Alona Muzikansky, et al.. (2024). The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC. The Oncologist. 29(7). 609–618. 8 indexed citations
3.
Seifert, Michael, et al.. (2024). β1 integrin mediates unresponsiveness to PI3Kα inhibition for radiochemosensitization of 3D HNSCC models. Biomedicine & Pharmacotherapy. 171. 116217–116217. 3 indexed citations
4.
Tzeng, Alice, Kelly Fitzgerald, Jaclyn LoPiccolo, et al.. (2023). Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study. JTO Clinical and Research Reports. 4(10). 100559–100559. 6 indexed citations
5.
Zhu, Lingling, et al.. (2023). Effect of Contralateral Esophagus Sparing in Hypofractionated Radiotherapy for Ultra-Central NSCLC. International Journal of Radiation Oncology*Biology*Physics. 117(2). e82–e82. 1 indexed citations
6.
Fell, Gillian L., Lajos V. Kemény, Claire Y. Fung, et al.. (2022). β-Endorphin mediates radiation therapy fatigue. Science Advances. 8(50). eabn6025–eabn6025. 7 indexed citations
7.
Davoudi, Farideh, Satoshi Yoda, Ellen Murchie, et al.. (2021). Alginate-based 3D cancer cell culture for therapeutic response modeling. STAR Protocols. 2(2). 100391–100391. 4 indexed citations
8.
McClatchy, David M., Henning Willers, Aaron N. Hata, et al.. (2020). Modeling Resistance and Recurrence Patterns of Combined Targeted–Chemoradiotherapy Predicts Benefit of Shorter Induction Period. Cancer Research. 80(22). 5121–5133. 8 indexed citations
9.
Kamran, Sophia C., Christine E. Eyler, Jochen K. Lennerz, et al.. (2020). Evolutionary Analysis of Pre- and Post-treatment Molecular Diversity in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation (CRT) and a KRAS Mutation-targeted Radiosensitizer. International Journal of Radiation Oncology*Biology*Physics. 108(3). S57–S57.
10.
Grassberger, Clemens, David M. McClatchy, Changran Geng, et al.. (2019). Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies. Cancer Research. 79(14). 3776–3788. 24 indexed citations
11.
Kamran, Sophia C., Jochen K. Lennerz, Claire A. Margolis, et al.. (2019). Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer. Clinical Cancer Research. 25(18). 5561–5571. 62 indexed citations
12.
Paganetti, Harald, Eleanor A. Blakely, Alejandro Cárabe, et al.. (2019). Report of the AAPM TG‐256 on the relative biological effectiveness of proton beams in radiation therapy. Medical Physics. 46(3). e53–e78. 212 indexed citations breakdown →
13.
Khandekar, Melin J., Zofia Piotrowska, Henning Willers, & Lecia V. Sequist. (2018). Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung Cancers. The Oncologist. 23(9). 1054–1062. 8 indexed citations
14.
Han, Jing, Lynnette Marcar, Joshua C. Black, et al.. (2017). Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway. Cancer Research. 77(8). 2018–2028. 77 indexed citations
15.
Geng, H., Haoyu Zhong, T Giaddui, et al.. (2017). Knowledge Engineering–Based Quality Evaluation of RTOG 1308 Proton Treatment plans. International Journal of Radiation Oncology*Biology*Physics. 99(2). E661–E662. 1 indexed citations
16.
Coleman, C. Norman, Geoff S. Higgins, J. Martin Brown, et al.. (2016). Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials. Clinical Cancer Research. 22(13). 3138–3147. 59 indexed citations
17.
Liu, Qi, Meng Wang, Jing Han, et al.. (2015). Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers. Molecular Cancer Research. 13(4). 713–720. 29 indexed citations
18.
Wang, Meng, Patricia Greninger, Anurag Singh, et al.. (2014). EGFR-Mediated Chromatin Condensation Protects KRAS-Mutant Cancer Cells against Ionizing Radiation. Cancer Research. 74(10). 2825–2834. 55 indexed citations
19.
Wang, Meng, Liliana Gheorghiu, Patricia Greninger, et al.. (2013). EGFR-Activating Mutations Correlate with a Fanconi Anemia–like Cellular Phenotype That Includes PARP Inhibitor Sensitivity. Cancer Research. 73(20). 6254–6263. 35 indexed citations
20.
Wang, Meng, David M. Sander, Liliana Gheorghiu, et al.. (2011). EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks. Cancer Research. 71(19). 6261–6269. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026